Leslie William Miller MD
Adult Congenital Heart Disease
Professor of Medicine, University S Fla College of Medicine
Join to View Full Profile
2 Tampa General CirSTC 5075Tampa, FL 33606
Phone+1 813-259-0600
Fax+1 813-259-8676
Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1981 - 1982
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1978 - 1980
University of Missouri-ColumbiaInternship, Internal Medicine, 1974 - 1975
University of Missouri-Columbia School of MedicineClass of 1974
Certifications & Licensure
FL State Medical License 2010 - 2027
MD State Medical License 2008 - 2017
DC State Medical License 2006 - 2010
MN State Medical License 1998 - 2006
IA State Medical License 1977 - 1978
IL State Medical License 1976 - 1978
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2012, 2014
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure Start of enrollment: 2007 Jul 01
Publications & Presentations
PubMed
- 59 citationsRandomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure.Emerson C Perin, Kenneth M Borow, Timothy D Henry, Farrell O Mendelsohn, Leslie W Miller
Journal of the American College of Cardiology. 2023-03-07 - 11 citationsStromal Cell–Derived Factor-1 Plasmid Treatment for Patients With Peripheral Artery Disease (STOP-PAD) Trial: Six-Month Results:Tarek A Hammad, John H. Rundback, Matthew C. Bunte, Leslie W. Miller, Parag D Patel
Journal of Endovascular Therapy. 2020-05-18 - 65 citationsUse of Ventricular Assist Devices and Heart Transplantation for Advanced Heart Failure.Leslie W. Miller, Emma J. Birks, Maya Guglin, Harveen K. Lamba, O.H. Frazier
Circulation Research. 2019-05-24
Journal Articles
- Cardiac Ejection FractionLeslie Miller, MD, JACC: Cardiovascular Imaging
- Original Investigation Editorial Comment Cardiac Ejection Fraction: New Insights About Its Dynamic Nature∗Leslie Miller, MD, ScienceDirect
Press Mentions
BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind CardiAMP HF II Clinical Trial of the Company’s Lead Cell Therapy for Treatment of Heart FailureMay 1st, 2025- Recent Controlled Study Validates the Significantly Lower Hemolysis of the SHA Whisper Device over Impella CPMarch 11th, 2025
- Recent Controlled Study Validates the Significantly Lower Hemolysis of the SHA Whisper Device over Impella CPMarch 11th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
